Health Media Articles
Excerpts of Key Health Media Articles from Major Media


Below are many highly revealing excerpts of important health articles reported in the mainstream media suggesting a cover-up. Links are provided to the full articles on major media websites. If any link fails to function, read this webpage. These health articles are listed by article date. You can also explore the articles listed by order of importance or by date posted. By choosing to educate ourselves on these important issues and to spread the word, we can and will build a brighter future.


Health Media Articles


Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

A Cloud Still Hangs Over Bhopal
2009-12-03, New York Times
http://www.nytimes.com/2009/12/03/opinion/03mehta.html

This is the 25th anniversary of the Bhopal gas disaster. [It] started one night when a pesticide plant owned by the American chemical giant Union Carbide leaked a cloud of poisonous gas. Before the sun rose, almost 4,000 human beings capable of love and anguish sank to their knees and did not get up. Half a million more fell ill, many with severely damaged lungs and eyes. An additional 15,000 people have since died from the aftereffects, and 10 to 30 people are said to die every month from exposure to the hundreds of tons of toxic waste left over in the former factory. But amazingly, the site still has not been cleaned up, because Dow Chemical, which since acquired Union Carbide, refuses to accept any responsibility. In 2001, the maker of napalm married the bane of Bhopal: Dow Chemical bought Union Carbide for $11.6 billion and promptly distanced itself from the disaster. Union Carbide and Dow were allowed to get away with it because of the international legal structures that protect multinationals from liability. Union Carbide sold its Indian subsidiary and pulled out of India. Warren Anderson, the Union Carbide chief executive at the time of the gas leak, lives in luxurious exile in the Hamptons, even though there’s an international arrest warrant out for him for culpable homicide. The Indian government has yet to pursue an extradition request. Imagine if an Indian chief executive had jumped bail for causing an industrial disaster that killed tens of thousands of Americans. What are the chances he’d be sunning himself in Goa?

Note: For lots more from reliable sources on corporate corruption, click here.




Health care lessons from Europe
2009-11-29, San Francisco Chronicle (San Francisco's leading newspaper)
http://www.sfgate.com/cgi-bin/article.cgi?file=/c/a/2009/11/29/MN3U1AL75B.DTL

Critics point to Canada and Britain as the poster children of what could happen here with a "government takeover" of health coverage. But three other wealthy nations - the Netherlands, Switzerland and Germany - offer much closer parallels, as well as lessons. Health care systems in the three nations more closely resemble the U.S. system of insurance-based coverage. Holland and Switzerland rely exclusively on private insurance, and all three rely on private doctors. The three European nations deliver universal coverage and world-class quality at a fraction of what Americans spend. All of them require that everyone purchase insurance, make sure everyone can afford it and ban insurers from such practices as refusing to cover the sick that are common in the United States. European health care is universal, but contrary to popular perception, it is not all nationalized. Most of Europe spends about 10 percent of its national income on health care and covers everyone. The United States will spend 18 percent this year and leave 47 million people uninsured. Europe has more doctors, more hospital beds and more patient visits than the United States. Take Switzerland: 4.9 doctors per thousand residents compared with 2.4 in the United States. And cost? The average cost for a hospital stay is $9,398 in relatively high-cost Switzerland and $17,206 in the United States.

Note: Maybe it boils down to whether we want our health controlled more by profit motive or by government bureaucracies One thing is for sure, the average U.S. citizen is getting much less for a greater cost than those in other developed countries.




Food Stamp Use Soars, and Stigma Fades
2009-11-29, New York Times
http://www.nytimes.com/2009/11/29/us/29foodstamps.html

With food stamp use at record highs and climbing every month, a program once scorned as a failed welfare scheme now helps feed one in eight Americans and one in four children. It has grown so rapidly in places so diverse that it is becoming nearly as ordinary as the groceries it buys. More than 36 million people use inconspicuous plastic cards for staples like milk, bread and cheese, swiping them at counters in blighted cities and in suburbs pocked with foreclosure signs. Virtually all have incomes near or below the federal poverty line, but their eclectic ranks testify to the range of people struggling with basic needs. They include single mothers and married couples, the newly jobless and the chronically poor, longtime recipients of welfare checks and workers whose reduced hours or slender wages leave pantries bare. There are 239 counties in the United States where at least a quarter of the population receives food stamps, according to an analysis of local data collected by The New York Times. In more than 750 counties, the program helps feed one in three blacks. In more than 800 counties, it helps feed one in three children. In the Mississippi River cities of St. Louis, Memphis and New Orleans, half of the children or more receive food stamps. Even in Peoria, Ill. — Everytown, U.S.A. — nearly 40 percent of children receive aid. While use is greatest where poverty runs deep, the growth has been especially swift in once-prosperous places hit by the housing bust.

Note: For more from reliable sources on the impacts and realities of the Wall Street financial crisis, click here.




GlaxoSmithKline pulls swine flu vaccines in Canada
2009-11-24, USA Today
http://www.usatoday.com/news/health/2009-11-24-glaxo-flu-vaccine-pull_N.htm

Drug company GlaxoSmithKline has told Canadian doctors to stop using one lot of its H1N1 vaccine until an investigation into a higher-than-expected number of severe allergic reactions is completed. The U.S. vaccine will not be identical to Arepanrix, the GSK H1N1 vaccine used in Canada. Arepanrix contains an adjuvant, a substance designed to boost the immune response, but adjuvants have never been approved for use in U.S. flu vaccines. Almost all of the 172,000 doses in question, distributed the week of Nov. 2 to six Canadian provinces, already have been administered, said Geoffrey Matthews, a spokeswoman for the Public Health Agency of Canada, which, with GSK and Health Canada, is investigating cases of anaphylaxis. Symptoms of anaphylaxis include trouble breathing, chest tightness and swelling of the mouth and throat. Six cases have been reported, Matthews says. In the USA, the Vaccine Adverse Event Reporting System said that as of Nov. 13 it had received 116 reports of serious health events related to the vaccine, including eight deaths – similar to the number in previous years after a similar number of seasonal flu vaccine doses had been shipped.

Note: For lots more on the risks of swine flu vaccines, click here.




In Ukraine, H1N1 pandemic sets off panic and politicking
2009-11-21, Washington Post
http://www.washingtonpost.com/wp-dyn/content/article/2009/11/20/AR20091120040...

As the pandemic H1N1 influenza surges with the onset of winter, the nations of Eastern Europe and the former Soviet Union appear particularly vulnerable to the deadly virus. Burdened with weak health-care systems, relatively inexperienced news media outlets and shaky governments that have little public trust, the region also seems ripe for panic and political strife over the flu. The potential for trouble is already on display in Ukraine, where 1.5 million of its 46 million people have had diagnoses of flu and respiratory illnesses since the start of the outbreak and 356 have died, according to the government. More telling than the numbers, however, has been the widespread fear the virus has caused in Ukraine, and the outsize impact it has had on the nation's political landscape. Anxious residents have overwhelmed hospitals and pharmacies, buying up supplies of medicine, gauze masks and home remedies such as lemons and garlic. Rumors have proliferated that people are dying of a new, more lethal strain of the virus. Semyon Gluzman, a psychiatrist and Soviet-era dissident in Kiev, said the fear was a rational response in a nation with a dysfunctional health-care system and a corrupt, ineffective government. "What we're seeing is a normal, psychological reaction to the complete incompetence of the state authorities," he said. "People are scared, and they don't know who to trust anymore."




Signs That Swine Flu Has Peaked
2009-11-20, New York Times
http://www.nytimes.com/2009/11/21/health/21flu.html

Although federal health officials decline to use the word "peaked," the current wave of swine flu appears to have done so in the United States. Flu activity is coming down in all regions of the country, the Centers for Disease Control and Prevention said Friday, though it is still rising in Hawaii, Maine and some isolated areas. The World Health Organization said Friday that there were "early signs of a peak" in much of the United States. On Wednesday, the American College Health Association, which surveys over 250 colleges with more than three million students, said new cases of flu had dropped in the week ending Nov. 13. It was the first drop since school resumed in the fall, and it was significant – new cases were down 27 percent from the week before. And on Friday, Quest Diagnostics, the country's largest laboratory, said its tests of 142,000 suspected flu specimens since May showed that the flu peaked in late October. Nonetheless, Dr. Anne Schuchat, the director of immunization and respiratory diseases at the C.D.C., chose her words carefully, saying: "I wish I knew if we had hit the peak. Even if a peak has occurred, half the people who are going to get sick haven't gotten sick yet." The drop was clearly not caused by the swine flu vaccine drive, which has not gone as fast as the authorities had hoped.

Note: Just like the avian flu scare a few years ago, the swine flu hype has turned out to be largely a whimper, yet the pharmaceutical companies are happy, as again they have made billions of dollars from the massive amonts of vaccines and drugs purchased by the government with your tax dollars. For more, click here and here.




Uninsured trauma patients are much more likely to die
2009-11-17, Los Angeles Times
http://www.latimes.com/news/nationworld/nation/la-sci-trauma-uninsured17-2009...

Patients who lack health insurance are more likely to die from car accidents and other traumatic injuries than people who belong to a health plan -- even though emergency rooms are required to care for all comers regardless of ability to pay. An analysis of 687,091 patients who visited trauma centers nationwide from 2002 to 2006 found that the odds of dying from injuries were almost twice as high for the uninsured than for patients with private insurance, researchers reported in Archives of Surgery. The research team from Harvard University and Brigham and Women's Hospital in Boston used information from 1,154 U.S. hospitals that contribute to the National Trauma Data Bank. The risk of death was 80% higher for patients without any insurance, the report said. The researchers also did a separate analysis of 209,702 trauma patients ages 18 to 30 because they were less likely to have chronic health conditions that might complicate recovery. Among these younger patients, the risk of death was 89% higher for the uninsured, the study found.

Note: For many highly informative reports on important health issues, click here.




Drug Makers Raise Prices in Face of Health Care Reform
2009-11-16, New York Times
http://www.nytimes.com/2009/11/16/business/16drugprices.html

Even as drug makers promise to support Washington's health care overhaul by shaving $8 billion a year off the nation's drug costs after the legislation takes effect, the industry has been raising its prices at the fastest rate in years. In the last year, the industry has raised the wholesale prices of brand-name prescription drugs by about 9 percent, according to industry analysts. That will add more than $10 billion to the nation's drug bill, which is on track to exceed $300 billion this year. By at least one analysis, it is the highest annual rate of inflation for drug prices since 1992. The drug trend is distinctly at odds with the direction of the Consumer Price Index, which has fallen by 1.3 percent in the last year. Critics say the industry is trying to establish a higher price base before Congress passes legislation that tries to curb drug spending in coming years. "When we have major legislation anticipated, we see a run-up in price increases," says Stephen W. Schondelmeyer, a professor of pharmaceutical economics at the University of Minnesota. A Harvard health economist, Joseph P. Newhouse, said he found a similar pattern of unusual price increases after Congress added drug benefits to Medicare a few years ago, giving tens of millions of older Americans federally subsidized drug insurance. Just as the program was taking effect in 2006, the drug industry raised prices by the widest margin in a half-dozen years. "They try to maximize their profits," Mr. Newhouse said.

Note: For lots more from reliable sources on corporate corruption, click here.




Stop Annual Mammograms, Govt. Panel Tells Women Under 50
2009-11-16, ABC News
http://abcnews.go.com/Health/OnCallPlusBreastCancerNews/mammogram-guidelines-...

For the first time in 20 years, a government panel is telling women in their [forties] to stop getting routine mammograms and recommending that a host of other breast cancer screenings slow down. The United States Preventive Service Task Force announced ... that it recommends against annual mammograms for women age 40 to 49 because, they say, the benefits of testing do not outweigh the "harms" and risks. USPSTF still recommends doctors start screening all women over age 50, but with a mammogram once every two years instead of annually. The task force also ... said evidence was insufficient to recommend mammograms for women older than 74. The recommendations announced today, which contradict the American Cancer Society, have already pitted doctors, women, insurers and radiology groups in a fierce debate about who should get a mammogram and when. Many patient advocates wonder if money fueled the decision. However, Dr. Diana Petitti, vice chair of USPSTF, said the task force never looked at costs in their research or their recommendations. Instead, the task force reviewed a number of studies to compile the benefits of mammograms, such as how many cancers were detected and how many lives were saved, and the harms of mammograms, such as how many false positives popped up, how many unnecessary tests were done and how much extra radiation women were exposed to during the false positive testing.

Note: For a powerful article compiling important information and key quotes of doctors and researchers revealing the dangers of mammograms, click here.




In House, Many Spoke With One Voice: Lobbyists
2009-11-15, New York Times
http://www.nytimes.com/2009/11/15/us/politics/15health.html

In the official record of the historic House debate on overhauling health care, the speeches of many lawmakers echo with similarities. Often, that was no accident. Statements by more than a dozen lawmakers were ghostwritten, in whole or in part, by Washington lobbyists working for Genentech, one of the world's largest biotechnology companies. E-mail messages obtained by The New York Times show that the lobbyists drafted one statement for Democrats and another for Republicans. The lobbyists ... were remarkably successful in getting the statements printed in the Congressional Record under the names of different members of Congress. Genentech, a subsidiary of the Swiss drug giant Roche, estimates that 42 House members picked up some of its talking points – 22 Republicans and 20 Democrats, an unusual bipartisan coup for lobbyists. In an interview, Representative Bill Pascrell Jr., Democrat of New Jersey, said: "I regret that the language was the same. I did not know it was." He said he got his statement from his staff and "did not know where they got the information from." In recent years, Genentech's political action committee and lobbyists for Roche and Genentech have made campaign contributions to many House members. And company employees have been among the hosts at fund-raisers for some of those lawmakers.

Note: For revealing reports from major media sources on government corruption, click here.




Swine flu skepticism demands deft response
2009-11-12, Reuters News
http://www.reuters.com/article/GCA-SwineFlu/idUSTRE5A52FU20091112

European scientists and health authorities are facing angry questions about why H1N1 flu has not caused death and destruction on the scale first feared, and they need to respond deftly to ensure public support. Accusations are flying in British and French media that the pandemic has been "hyped" by medical researchers to further their own cause, boost research grants and line the pockets of drug companies. Britain's Independent newspaper this week asked "Pandemic? What Pandemic?." France's Le Parisien newspaper ran the headline: "Swine flu: why the French distrust the vaccine" and noted a gap between the predicted impact of H1N1 and the less dramatic reality. "Dangerous liaisons between certain experts, the labs and the government, the obscurity of the contracts between the state and the pharma firms have added to the doubt." In Britain, health authorities' original worst-case scenario -- which said as many as 65,000 could die from H1N1 -- has twice been revised down and the prediction is now for around 1,000 deaths, way below the average annual toll of 4,000 to 8,000 deaths from seasonal winter flu.

Note: It's quite interesting and telling that a thorough Internet seach showed that no major media picked up this article from Reuters News Agency




9/11's delayed legacy: cancer for many of the rescue workers
2009-11-11, The Guardian (One of the UK's leading newspapers)
http://www.guardian.co.uk/world/2009/nov/11/cancer-new-york-rescuers

A spate of recent deaths of New York police and fire officers who took part in the emergency operation at Ground Zero after the 9/11 attacks has heightened fears that it could be the start of a delayed epidemic of cancer-related illness. Five firefighters and police officers, all of whom were involved in the rescue and clear-up at the site of the collapsed Twin Towers, have died of cancer in the past three months, the oldest being 44. Three died last month within a four-day period. Up to 70,000 people took part in the massive operation at Ground Zero, including police, firefighters and construction workers who came to New York voluntarily from all over the US. Many worked for months amid a toxic soup of dust and chemicals. Amid the pollutants within the giant pile of 1.8m tons of debris and the surrounding air were ... about 1,000 tons of asbestos that was used in the construction of the Twin Towers, pulverised lead from computers, mercury and highly carcinogenic by-products from the burning of plastics and chlorinated chemicals. No official tally is available for the number of those who have died as a result of the 9/11 clear-up. The New York state health department has recorded 817 deaths of emergency workers. Claire Calladine, a campaigner who runs the organisation 9/11 Health Now, said the fear was that the recent rise in cancer cases was just the start. "We have only seen the tip of the iceberg. How bad will it get – that is the big question."

Note: To read important questions raised by hundreds of government officials, academics and professionals about what really happened on 9/11, click here and here.




Chemicals in Our Food, and Bodies
2009-11-08, New York Times
http://www.nytimes.com/2009/11/08/opinion/08kristof.html

Your body is probably home to a chemical called bisphenol A, or BPA. It’s a synthetic estrogen that United States factories now use in everything from plastics to epoxies — to the tune of six pounds per American per year. More than 92 percent of Americans have BPA in their urine, and scientists have linked it ... to everything from breast cancer to obesity, from attention deficit disorder to genital abnormalities in boys and girls alike. Now it turns out it’s in our food. Consumer Reports magazine tested an array of brand-name canned foods for a report in its December issue and found BPA in almost all of them. The magazine says that relatively high levels turned up, for example, in Progresso vegetable soup, Campbell’s condensed chicken noodle soup, and Del Monte Blue Lake cut green beans. The magazine also says it found BPA in the canned liquid version of Similac Advance infant formula ... and in canned Nestlé Juicy Juice. The BPA in the food probably came from an interior coating used in many cans. More than 200 other studies have shown links between low doses of BPA and adverse health effects, according to the Breast Cancer Fund, which is trying to ban the chemical from food and beverage containers. “The vast majority of independent scientists — those not working for industry — are concerned about early-life low-dose exposures to BPA,” said Janet Gray, a Vassar College professor who is science adviser to the Breast Cancer Fund.

Note: For more on BPA and other health issues, click here.




Outrage as Doctors' Group Allows Coca-Cola to Sponsor Health Advice
2009-11-05, Fox News/Associated Press
http://www.foxnews.com/story/0,2933,571930,00.html

Advice about soft drinks and health from one of the nation's largest doctors groups will soon be brought to you by Coke. The American Academy of Family Physicians has prompted outcry and lost members over its new six-figure alliance with the Coca-Cola Co. The deal will fund educational materials about soft drinks for the academy's consumer health and wellness Web site, www.FamilyDoctor.org. "Coca-Cola, like other sodas, causes enormous suffering and premature death by increasing the risks of obesity, diabetes, heart attacks, gout, and cavities," Harvard University nutrition expert Dr. Walter Willett said in an e-mail. He said the academy "should be a loud critic of these products and practices, but by signing with Coke their voice has almost surely been muzzled." Dr. Henry Blackburn, a University of Minnesota public health specialist, said the deal "will inevitably have a chilling effect on the focus of their message in regards to sweet drinks."

Note: For more on corruption in the medical/corporate complex, click here.




Drugmakers' Payments Draw Heat
2009-11-04, BusinessWeek magazine
http://www.businessweek.com/bwdaily/dnflash/content/nov2009/db2009114_700374.htm

A $112 million settlement involving alleged drug kickbacks that the Justice Dept. announced with the nation's largest nursing home pharmacy and a generic drug manufacturer on Nov. 3 is part of a wide-ranging investigation of suspected Medicaid fraud by the pharmaceutical industry. Critics say the continuing probe, which involves ... major drugmakers, highlights what they describe as an industry practice of paying money to outfits that provide drugs to consumers, in return for preferential treatment. Because those alleged payoffs have the effect of compromising patient care and driving up costs for government and private health insurers, cases like the settlement unsealed with Omnicare (OCR) in Covington, Ky., and IVAX Pharmaceuticals in Weston, Fla., could bolster opposition to the controversial deal the Obama Administration reached with the pharmaceutical industry to win its support for health-reform legislation. Many Democrats say the Administration should have asked for much bigger cost savings from drugmakers. Patrick Burns, a spokesman for Taxpayers Against Fraud, a nonprofit Washington group that promotes whistleblower suits, says the Justice Dept. is backed up with pharmaceutical fraud cases. Since drugmakers offer so many similar products, he contends, they rely on kickbacks to give their products a market edge. "In the pharmaceutical industry, the business isn't selling the best drug, it's the best scheme of kickbacks to the prescriber."

Note: For lots more from reliable sources on corporate corruption, click here.




Depression link to processed food
2009-11-02, BBC
http://news.bbc.co.uk/2/hi/8334353.stm

Eating a diet high in processed food increases the risk of depression, research suggests. What is more, people who ate plenty of vegetables, fruit and fish actually had a lower risk of depression, the University College London team found. Data on diet among 3,500 middle-aged civil servants was compared with depression five years later, the British Journal of Psychiatry reported. They split the participants into two types of diet - those who ate a diet largely based on whole foods, which includes lots of fruit, vegetables and fish, and those who ate a mainly processed food diet, such as sweetened desserts, fried food, processed meat, refined grains and high-fat dairy products. After accounting for factors such as gender, age, education, physical activity, smoking habits and chronic diseases, they found a significant difference in future depression risk with the different diets. Those who ate the most whole foods had a 26% lower risk of future depression than those who at the least whole foods. By contrast people with a diet high in processed food had a 58% higher risk of depression than those who ate very few processed foods.

Note: For an excellent article revealing dramatic improvements in the behavior of children at a school which transformed the children's diet in a major experiment being modeled by other schools, click here. For key reports from major media sources on important health issues, click here.




In Germany, a Better Vaccine for Politicians?
2009-10-27, Time magazine
http://www.time.com/time/health/article/0,8599,1932366,00.html

As Germany launched its mass-vaccination program against the H1N1 flu virus on Monday, the government found itself fending off accusations of favoritism because it was offering one vaccine believed to have fewer side effects to civil servants, politicians and soldiers, and another, potentially riskier vaccine to everyone else. The German government prepared for its mass-vaccination campaign earlier this year by ordering 50 million doses of the Pandemrix vaccine. The vaccine, manufactured by GlaxoSmithKline, contains an immunity-enhancing chemical compound, known as an adjuvant, whose side effects are not yet entirely known. The Interior Ministry confirmed that it had ordered a different vaccine, Celvapan, for government officials and the military. Celvapan, which is made by U.S. pharmaceutical giant Baxter, does not contain an adjuvant and is believed to have fewer side effects.

Note: For a revealing article exposing more on this critical issue, click here. Other thoroughly researched articles suggesting a major cover-up around the swine flu vaccine are available here.




Why governments are selling Vitamin D short
2009-10-23, Financial Times
http://www.ft.com/cms/s/2/11180df8-beaa-11de-b4ab-00144feab49a.html

Reinhold Vieth, [a] professor at the University of Toronto’s Department of Laboratory Medicine and Patho-biology, ... is among the most knowledgeable people in the world on the subject of vitamin D. In the US and Canada, official vitamin D policy is set by the Institute of Medicine. And in the opinion of Vieth, the current recommendations – 200 International Units per day for people under 50, 400 for people aged 51-70, and 600 for those 71 and older – are outrageously low. Vieth and other vitamin D advocates have good reason to think there will be minimal changes made to dietary guidelines. Last December, the World Health Organisation’s International Agency for Research on Cancer issued a 465-page report that concluded there was no need to raise vitamin D recommendations. “The evidence favouring vitamin D is probably as good as the evidence that shows smoking is bad for you,” Vieth says, explaining that just as smoking is correlated with certain cancers, so are low vitamin D levels. “But when these government officials see the same kind of evidence that deals with vitamin D as they see with smoking they go, ‘Oh wait a minute. We can’t really trust this.’” Vieth pauses, as though he can barely stand to talk about such a miserable state of affairs. “It’s easy to say ‘don’t do something – don’t smoke’. It’s very hard to say ‘take this. Take vitamin D.’”

Note: For many key reports from reliable sources on important health issues, click here.




Swine Flu Cases Overestimated
2009-10-21, CBS News
http://www.cbsnews.com/stories/2009/10/21/cbsnews_investigates/main5404829.shtml

If you've been diagnosed "probable" or "presumed" 2009 H1N1 or "swine flu" in recent months, you may be surprised to know this: odds are you didn’t have H1N1 flu. In fact, you probably didn’t have flu at all. That's according to state-by-state test results obtained in a three-month-long CBS News investigation. Why the uncertainty about who has and who hasn't had H1N1 flu? In late July, the CDC abruptly advised states to stop testing for H1N1 flu, and stopped counting individual cases. CBS News learned that the decision to stop counting H1N1 flu cases was made so hastily that states weren't given the opportunity to provide input. When CDC did not provide us [CBS News] with the material, we filed a Freedom of Information request with the Department of Health and Human Services (HHS). More than two months later, the request has not been fulfilled. We also asked CDC for state-by-state test results prior to halting of testing and tracking, but CDC was again, initially, unresponsive. We asked all 50 states for their statistics on state lab-confirmed H1N1 prior to the halt of individual testing and counting in July. The vast majority of cases were negative for H1N1 as well as seasonal flu, despite the fact that many states were specifically testing patients deemed to be most likely to have H1N1 flu, based on symptoms and risk factors, such as travel to Mexico. With most cases diagnosed solely on symptoms and risk factors, the H1N1 flu epidemic may seem worse than it is.

Note: Some states found that less than 2% of cases claimed to be swine flu turned out to be the real thing. The numbers have been greatly exaggerated. Yet the drug companies raked in billions of dollars in profit from all the fear mongering. For more reliable information on this, click here and here.




Key drug facts left off labels, experts say
2009-10-21, MSNBC/Associated Press
http://www.msnbc.msn.com/id/33419377/ns/health-more_health_news

Did you know that Lunesta will help you fall asleep just 15 minutes faster? Or that a higher dose of the osteoporosis drug Zometa could damage a cancer patient’s kidneys and raise their risk of death? Chances are you didn’t, and neither did your doctor. Much of what the Food and Drug Administration knows about a drug’s safety and effectiveness is not included on the label, say two drug safety experts who are calling on the agency to make that information more accessible. In ... the New England Journal of Medicine, researchers ... argue that drug labels don’t reflect the nuanced decisions the FDA makes when deciding to approve a drug. The editorial from Drs. Lisa Schwartz and Steven Woloshin recommends easy-to-read fact boxes to help patients weigh the benefits and risks of medications. If drug labels sometimes exaggerate benefits and play down drug risks, the authors say there’s a very good reason: they are written by drugmakers. While FDA must approve the final labeling, the actual language is drafted by the manufacturer, with input from FDA scientists. The labeling is based on results from company studies, which generally compare results for patients taking the drug versus those taking placebo. If FDA decides the drug’s ability to treat or prevent a disease outweighs its side effects, the agency is obligated to approve it. But Schwartz and Woloshin point out that benefits may be slim and potential harms may not be fully understood. “The take home point is that just because a drug is approved doesn’t mean it works very well,” said Schwartz, in an interview with the Associated Press. “You really need to know more to see whether it’s worth the cost.” Schwartz and Woloshin say FDA labeling frequently fails to provide a full picture of a drug’s effects.

Note: For a powerful summary of corruption in the pharmaceutical industry, click here.





Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.


As of July 21st, 2014, we're $4,400 in the red. Kindly donate here to support this vital work.

Subscribe here to our free email list for two information-packed emails per week.


WantToKnow.info is a PEERS empowerment website

"Dedicated to the greatest good of all who share our beautiful world"